01020325 million of peopleProtectedwithvaccinesprocuredbyPAHO8 of 10Births in LAC are protected with vaccines procured by PAHO 675000people with HIVAIDS accessline treatment every yearOUR REACH in PR ID: 856574
Download Pdf The PPT/PDF document "Overview of PAHO Procurement MechanismsO..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1 01 02 03 Overview of PAHO Procurement Me
01 02 03 Overview of PAHO Procurement MechanismsOperations/LogisticsLogistics Challenges Key Priorities 25 million of people Protected with vaccines procured by PAHO 8 of 10 Births in LAC are protected with vaccines procured by PAHO 675,000 people with HIV/AIDS accessline treatment every year OUR REACH in PROCUREMENT PAHO/WHO
2 countriesterritories countriesterritori
countriesterritories countriesterritories Member States Procuring through PAHO Revolving Funds PAHO Procurement Mechanisms PAHO Revolving Fund PAHO Strategic Fund WHO Essential Medicines DiagnosticsKits Vector Control Other Strategic Products (e.g. Lab Equipment) Vaccines Syringes Cold Chain Equipment Other biologicals (e.
3 g. blood products)www.paho.org/revolving
g. blood products)www.paho.org/revolvingfundwww.paho.org/strategicfundLTAs including vaccines, immunoglobulins, syringes, and safety boxes74 LTAs Including HVI/AIDS, TB, Malaria, Antineoplastic, Antivirals (HCV), Immunosuppressive drugs, Hematologic, Surfactant Diagnostic kits PAHO/WHO PAHO/WHO 8 COVAX Procurement Strategy fo
4 r Covid19 vaccines in 2021Goal & Objecti
r Covid19 vaccines in 2021Goal & Objectives Balanced PortfolioReduce dependency of a specific vaccine platform or exporting regulatory dependency by having a balanced and geographically diverse portfolio. Goal: secure supply of at least 2BN doses of vaccine to be delivered to 186 countries by the end of 2021 Speed/equitable
5 Expedite access by establishing APCs to
Expedite access by establishing APCs to incentivize manuf. to scale up capacity and begin manufacturing.Volumessecure the needed doses (2BN) considering success rates of candidates.PriceAchieve the lowest prices by pooling demand and derisking manufacturers PAHO/WHO 50010001500200025003000350020192021 Air Shipments Covid-19 Sh
6 ipments increase of volume of doses proc
ipments increase of volume of doses procured 202MM Covid 488 MM doses 286 MMdoses 109% increase of volume of syringes procured 285MM units Covid 547 MM units 262 MMunits SyringesVaccinesAir Shipments Lead Time from placing POs: approx. 3m mfg+ 2m transit Procurement & Logistics Challenges 2019 vs 2021 Projection 80% Canada Gr
7 eenland United States of America Austral
eenland United States of America Australia Indonesia China South Korea Kazkahstan India Russia Mongolia Sri Lanka Philippines Mexico Guatemala El Salvador Honduras Colombia Venezuela Peru Ecuador Paraguay Argentina Chile Iraq Iran Democratic Republic of the congo Senegal Mali Libya Algeria Egypt Nigeria Niger Sudan Yemen Oman A
8 fghanistan Pakistan Nepal Thailand Malay
fghanistan Pakistan Nepal Thailand Malaysia Uzbekistan Saudi Arabia Kenya Angola Madagascar Namibia South Africa Bolivia Brazil Norway Sweden Belarus Germany France Spain Italy Ireland United Kingdom Portugal Denmark Netherlands Belgium Ukraine Turkey Tunisia Iceland PAHOs International Logistics for Vaccines and Pharmaceutical
9 s 2,711Shipmentsevery year PAHO ‘s
s 2,711Shipmentsevery year PAHO ‘s High Level Steps Purchase order sent to suppliers & consignee Suppliers is responsible for the delivery up to airport of destination (DPU/CIP incoterm 2020) Insurance of 110% Total PO value by supplierSupplier sends shipping documents to PAHO and consignee at least 5 days prior delivery d
10 ate. AWB temperature instructions. Ship
ate. AWB temperature instructions. Shipment execution & arrival follows WHO ‘ s Guidelines International Packaging and Shipping of Vaccines, and any related update for COVID 1234 PAHO/WHO PAHO/WHO CURRENT LOGISTICS ASPECTS AND CHALLENGES OperationsIn general, and with Covidvaccine Challenges Destination with strict custo
11 ms regulationsShipments are kept longer
ms regulationsShipments are kept longer at the airport Lack of cold chain storageat destinations (e.g. Small islands and Haiti) Considerable increases in Air Freight costs Challenging routes(Antigua/Grenada/Dominica/VEN) Lengthy transit time: Lack of direct flights for most PAHO destinations. Packaging validations 72hr avg Air
12 freight Capacity: Dry ice limitations o
freight Capacity: Dry ice limitations on flights PAHO/WHO KEY PRIORITIES – COVID - 19 LOGISTICS Caribbean and Central AmericaPriority to Covid19 vaccines and other vaccines and humanitarian supplies Temperature control management for cold chain during transit and at arrivalSecure necessary capacity for Covid19 vaccines a
13 nd existing vaccines shipmentsAirport op
nd existing vaccines shipmentsAirport operations during lockdownsInfrastructure/Security Service Capacity Priority Priorization Cold Chaintransit Local Cold chain facility Vaccine Procurement and Logistics in the Americas/ Covid PAHO Procurement & Supply Management (PRO) Meeting with ICAOSouth American Regional Office04 Decem